Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for RVP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 72.87M
March 31, 2026 70.09M
December 31, 2025 74.38M
September 30, 2025 76.78M
June 30, 2025 76.47M
March 31, 2025 76.61M
December 31, 2024 87.17M
September 30, 2024 83.46M
June 30, 2024 85.44M
March 31, 2024 99.66M
December 31, 2023 99.29M
September 30, 2023 99.42M
June 30, 2023 103.54M
March 31, 2023 107.47M
December 31, 2022 106.54M
September 30, 2022 108.98M
June 30, 2022 102.50M
March 31, 2022 105.32M
December 31, 2021 99.17M
September 30, 2021 79.60M
June 30, 2021 74.64M
March 31, 2021 67.84M
December 31, 2020 49.88M
September 30, 2020 39.12M
June 30, 2020 33.05M
Date Value
March 31, 2020 28.74M
December 31, 2019 28.54M
September 30, 2019 26.74M
June 30, 2019 25.77M
March 31, 2019 25.43M
December 31, 2018 25.61M
September 30, 2018 25.82M
June 30, 2018 25.94M
March 31, 2018 26.94M
December 31, 2017 27.17M
September 30, 2017 28.34M
June 30, 2017 27.71M
March 31, 2017 28.88M
December 31, 2016 28.11M
September 30, 2016 30.07M
June 30, 2016 30.16M
March 31, 2016 30.06M
December 31, 2015 31.03M
September 30, 2015 32.07M
June 30, 2015 32.36M
March 31, 2015 25.77M
December 31, 2014 26.83M
September 30, 2014 25.95M
June 30, 2014 25.53M
March 31, 2014 26.91M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 51.11B
AngioDynamics, Inc. 170.82M
Alphatec Holdings, Inc. 11.53M
AtriCure, Inc. 516.43M
Baxter International, Inc. 6.206B

Shareholders Equity (Quarterly) Related Metrics